The U.S. Food and Drug Administration has declined to approve an injectable version of Johnson & Johnson's drug Rybrevant for ...

The U.S. Preventive Services Task Force recommends a low-dose CT scan of the chest for anyone who is between ages 50 and 80 ...

Doctors at Chesapeake Regional Healthcare are able to minimize the pain lung cancer patients undergo with a one-and-done ...

GSK’s GSK’227 has gained Priority Medicines (PRIME) designation from the EMA for the treatment of relapsed ES-SCLC.

In 33 heavily pretreated NSCLC EGFR wild-type (EGFRwt) patients the combination of AFM24 and atezolizumab shows an overall ...

Discover the latest advancements in small cell lung cancer through Novotech CRO’s in-depth disease analysis. Gain valuable insights into novel therapies, ongoing clinical trials, and future ...

Lung cancer researcher, Bryant Kin, has been diagnosed with the disease despite never smoking himself in his life, he's ...

Lung cancer innovations are not only extending lives but also enhancing the quality of life for patients, offering renewed ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit looks back on the progress made toward better understanding and ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

An NIH modeling study examined the individual and combined effects of cancer prevention, screening, and treatment. A study ...

An FDA-approved drug used to treat multiple myeloma and lymphoma also shrank tumors in non-small cell lung cancer (NSCLC) ...